Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial
- Motzer, R.J.
- Russo, P.
- Grünwald, V.
- Tomita, Y.
- Zurawski, B.
- Parikh, O.
- Buti, S.
- Barthélémy, P.
- Goh, J.C.
- Ye, D.
- Lingua, A.
- Lattouf, J.-B.
- Albigès, L.
- George, S.
- Shuch, B.
- Sosman, J.
- Staehler, M.
- Vázquez Estévez, S.
- Simsek, B.
- Spiridigliozzi, J.
- Chudnovsky, A.
- Bex, A.
ISSN: 1474-547X, 0140-6736
Year of publication: 2023
Volume: 401
Issue: 10379
Pages: 821-832
Type: Article